Cargando…

Medication tendencies for inducing severe ocular surface symptoms in Japanese Stevens-Johnson Syndrome / toxic epidermal necrolysis patients

Detalles Bibliográficos
Autores principales:	Saito, Yoshiro, Ueta, Mayumi, Nakamura, Ryosuke, Sugiyama, Emiko, Maekawa, Keiko, Takahashi, Yukitoshi, Furuya, Hirokazu, Yagami, Akiko, Matsukura, Setsuko, Ikezawa, Zenro, Matsunaga, Kayoko, Sotozono, Chie, Aihara, Michiko, Kinoshita, Shigeru, Kaniwa, Nahoko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128208/ http://dx.doi.org/10.1186/2045-7022-4-S3-P88

Ejemplares similares

HLA association with antipyretic analgesics-induced Stevens-Johnson Syndrome / toxic epidermal necrolysis with severe ocular surface complications in japanese patients
por: Nakamura, Ryosuke, et al.
Publicado: (2014)

Independent strong association of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe mucosal involvement
por: Ueta, Mayumi, et al.
Publicado: (2014)

Plasma Lipid Profiling of Patients with Chronic Ocular Complications Caused by Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
por: Saito, Kosuke, et al.
Publicado: (2016)

Japan: Diagnosis and Management of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications
por: Sotozono, Chie, et al.
Publicado: (2021)

Predictive biomarkers for the progression of ocular complications in chronic Stevens-Johnson syndrome and toxic Eeidermal necrolysis
por: Yoshikawa, Yamato, et al.
Publicado: (2020)

Association of HLA class I and II gene polymorphisms with acetaminophen-related Stevens–Johnson syndrome with severe ocular complications in Japanese individuals
por: Ueta, Mayumi, et al.
Publicado: (2019)

Multi-state model for predicting ocular progression in acute Stevens-Johnson syndrome/toxic epidermal necrolysis
por: Kinoshita, Fumie, et al.
Publicado: (2021)

Editorial: The Updated Understanding of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
por: Kinoshita, Shigeru, et al.
Publicado: (2021)

In Silico Risk Assessment of HLA-A*02:06-Associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Caused by Cold Medicine Ingredients
por: Isogai, Hideto, et al.
Publicado: (2013)

Pathogenesis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications
por: Ueta, Mayumi
Publicado: (2021)

Challenges in the management of bilateral eyelid closure in Stevens-Johnson Syndrome
por: Aziza, Yulia, et al.
Publicado: (2022)

Implementation of Pharmacogenomic Information on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
por: Tsukagoshi, Eri, et al.
Publicado: (2021)

Toxic epidermal necrolysis and Stevens-Johnson syndrome
por: Harr, Thomas, et al.
Publicado: (2010)

Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis
por: Klimas, Natasha, et al.
Publicado: (2015)

Recent Dermatological Treatments for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Japan
por: Hsieh, Ming-Hsiu, et al.
Publicado: (2021)

Categorization of the Ocular Microbiome in Japanese Stevens–Johnson Syndrome Patients With Severe Ocular Complications
por: Ueta, Mayumi, et al.
Publicado: (2021)

Downregulation of interferon-γ-induced protein 10 in the tears of patients with Stevens-Johnson syndrome with severe ocular complications in the chronic stage
por: Ueta, Mayumi, et al.
Publicado: (2017)

Cold medicine-related Stevens–Johnson syndrome/toxic epidermal necrolysis with severe ocular complications–phenotypes and genetic predispositions
por: Ueta, Mayumi
Publicado: (2016)

Stevens–Johnson syndrome/toxic epidermal necrolysis associated with zonisamide
por: Vivar, Karina L., et al.
Publicado: (2017)

The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China
por: Yang, Shang-Chen, et al.
Publicado: (2018)

Ampicillin/sulbactam: Stevens-Johnson syndrome/toxic epidermal necrolysis
Publicado: (2021)

Recurrent Steven-Johnson/Toxic Epidermal Necrolysis Overlap Syndrome
por: Toledo-Martinez, Juan F, et al.
Publicado: (2022)

Scoring Assessments in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
por: Dobry, Allison S., et al.
Publicado: (2022)

Gene expression analysis of conjunctival epithelium of patients with Stevens-Johnson syndrome in the chronic stage
por: Ueta, Mayumi, et al.
Publicado: (2019)

Long-Term Benefits of Tear Exchangeable Limbal-Rigid Contact Lens Wear Therapy in Stevens–Johnson Syndrome Cases
por: Yoshikawa, Yamato, et al.
Publicado: (2023)

Strong association between hla-a*02:06 and acetaminophen-related stevens-johnson syndrome with severe mucosal involvements in the Japanese
por: Ueta, Mayumi, et al.
Publicado: (2014)

HLA class I and II gene polymorphisms in Stevens-Johnson syndrome with ocular complications in Japanese
por: Ueta, Mayumi, et al.
Publicado: (2008)

Aceclofenac induced Stevens-Johnson/toxic epidermal necrolysis overlap syndrome
por: Ameen, Kaderthambi Hajamohideen Nooru, et al.
Publicado: (2013)

Stevens-Johnson syndrome / toxic epidermal necrolysis: an Asia-Pacific perspective
por: Thong, Bernard Yu-Hor
Publicado: (2013)

Stevens-Johnson syndrome/toxic epidermal necrolysis presumably induced by norfloxacin
por: Maciejewska, Jolanta, et al.
Publicado: (2014)

The role of malignancy in the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis
por: Wu, Jennifer, et al.
Publicado: (2014)

New insights in Stevens Johnson syndrome/ toxic epidermal necrolysis syndrome
por: Schroeder, Jan, et al.
Publicado: (2014)

Ibuprofen induced Stevens-Johnson syndrome - toxic epidermal necrolysis in Nepal
por: Angadi, Siddheshwar S, et al.
Publicado: (2016)

Corrigendum to “The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China”
por: Yang, Shang-Chen, et al.
Publicado: (2018)

Topical moxifloxacin-induced toxic epidermal necrolysis and Stevens-Johnson syndrome
por: Dhavaleshwar, A, et al.
Publicado: (2019)

Study of Ocular Manifestations of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
por: Abrol, Arundha, et al.
Publicado: (2020)

Current Pharmacogenetic Perspective on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
por: Cheng, Lin
Publicado: (2021)

Allopurinol: Stevens Johnson syndrome/toxic epidermal necrolysis: case report
Publicado: (2022)

Study of genital manifestations of Stevens Johnson Syndrome/Toxic Epidermal Necrolysis
por: Gulanikar, Anirudha, et al.
Publicado: (2022)

Mapping of susceptible variants for cold medicine-related Stevens–Johnson syndrome by whole-genome resequencing
por: Kawai, Yosuke, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fmsaa6q7d3snjhr6jdh2rn1rq0